Global Health & Biotech Archives | Page 11 of 287 | Be Korea-savvy

Archive by category Global Health & Biotech

Philips joins Optum Healthcare’s network as a preferred provider in the USA

Philips joins Optum Healthcare’s network as a preferred provider in the USA

September 25, 2025 Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has entered a national partnership in the USA with Optum Healthcare. The inclusion of [...]

Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit

Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit

TOKYO, Sept. 24, 2025 (Korea Bizwire) – Healthcare must be recognized as the world’s most strategic investment in security, prosperity, and resilience—not as a financial burden—declared H.E. Dr. Majid Alfayyadh, Adviser at the Saudi Royal Court and Chief Executive Officer of King Faisal Specialist Hospital and Research Centre (KFSHRC), in his keynote at the C3 [...]

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

Research Triangle Park, N.C., Sept. 22, 2025 (Korea Bizwire) – AB-1005, a glial cell line-derived neurotrophic factor (GDNF) investigational gene therapy, is being evaluated for the treatment of moderate-stage Parkinson’s disease in the REGENERATE-PD trial   Sites in Poland and the United Kingdom have started randomizing participants, with sites in Germany actively screening and following shortly  [...]

WHO Disenfranchises the Public from Tobacco Control Conference as Registration Barriers Reach “Insane” Levels

WHO Disenfranchises the Public from Tobacco Control Conference as Registration Barriers Reach “Insane” Levels

MANILA, Philippines, Sept. 22, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today condemned the World Health Organisation’s Framework Convention on Tobacco Control (WHO FCTC) for erecting deliberate barriers to prevent public participation in the upcoming Conference of the Parties (COP11) scheduled for November in Geneva. Executive Coordinator Nancy [...]

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tablets Patients reported high satisfaction (>89%) with AUSTEDO XR, with 96% expressing interest in continuing treatment Almost all (>96%) patients relayed that AUSTEDO XR was easy to take PARSIPPANY, N.J. and TEL AVIV, Israel, [...]

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-’749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-’749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

  Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-’749) and its long-term systemic safety profile was consistent with other olanzapine formulations1 Additional new data comparing initiation of UZEDY® (risperidone) versus Invega Sustenna® (paliperidone palmitate) in hospitalized patients found that UZEDY was associated with [...]

KFSHRC to Participate in C3 Davos of Healthcare™ Japan Summit

KFSHRC to Participate in C3 Davos of Healthcare™ Japan Summit

TOKYO, Sept. 18, 2025 (Korea Bizwire) – King Faisal Specialist Hospital and Research Centre (KFSHRC) has announced its participation in the C3 Davos of Healthcare™ Japan Summit, taking place on September 24, 2025 under the theme “A Tri-Nation Collaboration: Building Bridges Beyond Borders in Healthcare,” bringing together global leaders, policymakers, investors, and innovators to foster [...]

Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO

Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO

Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, 18 September 2025 Michael Reitermann, Member of the Board of Directors since 2020, and an executive leader with broad experience both in the USA and Europe, has been appointed by the Board of Directors of Ascom Holding AG as Delegate of the Board of Directors [...]

At CPHI Frankfurt, TekniPlex Healthcare to Present Full Range of Barrier Blister Films, Customized Liquid Drug Delivery Solutions and Live Demonstrations of Latest Filling-Sealing Machine

At CPHI Frankfurt, TekniPlex Healthcare to Present Full Range of Barrier Blister Films, Customized Liquid Drug Delivery Solutions and Live Demonstrations of Latest Filling-Sealing Machine

Company will also highlight emerging pharmaceutical-rubber products, innovative liner portfolio and barrier cleanroom films and bags Wayne, PA, Sept. 17, 2025 (Korea Bizwire) – TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will spotlight its extensive portfolio of barrier blister films at CPHI Frankfurt, October 28-30. At Stand 8.0J25, the company will [...]